InkVivo Technologies AG

Private

LuganoHealthcare & Life Scienceshttps://www.inkvivo.tech/

Last Round

pre_seed

Aug 13, 2025

Total Funding Raised

$28,000

Company Overview

InkVivo Technologies AG is a biotechnology company that develops a next-generation drug delivery platform to improve therapeutic outcomes.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

drug delivery platformdrug formulationcontrolled releasesustained releasebiomaterialspolymer-based platformpharmaceutical co-developmentdrug reformulationproduct lifecycle extensionbioavailability enhancementcontract R&Dgastroretentive drug deliveryoral drug deliveryinjectable drug deliveryshear-thinning hydrogelAI-assisted designin silico formulationcomputational modeling

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

InkVivo Technologies AG Comparables

Compare InkVivo Technologies AG with similar companies based on industry and business-model similarity.

InkVivo Technologies AG comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Catalya	79%
InnoCore Pharmaceuticals	77%
Sustained Therapeutics	76%

View all Comparables

InkVivo Technologies AG Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
pre_seed	Aug 13, 2025
Grant	Nov 13, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Stefano Cerutti

Co-Founder and COO

Founding Team

InkVivo Technologies AG Investors

Notable investors and investment history

InkVivo Technologies AG investors
Investor	Rounds
TiVenture	pre_seed
Fondazione Agire	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Aug 13, 2025
$1.23M round led by TiVenture

View all signals

InkVivo Technologies AG Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

InkVivo Technologies AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about InkVivo Technologies AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersLugano

Employee Range11

Year Founded2023

Last FundingAug 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?